IMA vs MA · rev $9.2M vs P/E 38, rev $32.79B
ImageneBio, Inc. (IMA) versus Mastercard Inc (MA) — a side-by-side from cached financials, not a winner call.
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
Mastercard Inc (MA) is a credit services company listed on US. It is led by Michael Miebach.
Latest reported IMA revenue for 2023-12-31 was $9.2M. Net income was -$68.2M. Revenue was down 41.3% from 2022-12-31 to 2023-12-31. IMA currently screens at market cap $64.7M.
Latest reported MA revenue for 2025-12-31 was $32.79B. Net income was $14.97B. Revenue was up 16.4% from 2024-12-31 to 2025-12-31. MA currently screens at market cap $515.12B and trailing P/E 38.4.
IMA currently screens at market cap $64.7M. MA currently screens at market cap $515.12B and trailing P/E 38.4.
Not investment advice. Open the IMA and MA stock pages for the full models.
Not investment advice.